EUDA Health Holdings Limited
EUDAW
NASDAQ Capital Market0.02
USD
+0.00
- -
CIK
0001847846
ISIN
VGG3142E1218
CUSIP
G3142E121
Return %
Stock
S&P500
1Y
-75.45
18.21
3Y
-65.00
63.29
5Y
-91.55
74.90
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Alfred Lim
- Full Time Employees
- 123
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 60 Kaki Bukit Place Singapore CE Singapore 576151
- IPO Date
- Nov 18, 2022
- CIK
- 0001847846
- Website
- euda.com
- Similar Companies
- Business
- EUDA Health Holdings Limited EUDA Health Holdings Limited operates as a Singapore-based healthcare specialty company focused on non-invasive healthcare services, digital health platforms, and holistic wellness solutions primarily in Southeast Asia, including Singapore, Malaysia, China, and expanding into India and Indonesia. The company provides specialty care services through medical facilities and general practice clinics offering holistic treatments for various illnesses; digital healthcare via the proprietary MyEUDA app, which enables AI-driven teleconsultations, symptom triage, virtual doctor visits, prescription fulfillment, and home delivery of medications; lifestyle and wellness offerings such as bioenergy capsule therapies, EUDA Helixé supplements, stem cell-related regenerative medicine, wellness therapies, licensing of bioenergy cabins, wellness membership programs, and non-invasive solutions for immune optimization, aging, and chronic conditions like diabetes and gout; health plans including virtual GP consultations, COVID-19 support, health screenings, dental services, urgent care, specialist referrals, mental health, and physiotherapy; as well as property management services for shopping malls, business office buildings, residential apartments, and condominiums. Headquartered at 60 Kaki Bukit Place, #03-01, Eunos Techpark, Singapore 415979, the company was founded around 2019, went public in 2022 through a business combination with 8i Acquisition 2 Corp., and employs approximately 106 people under CEO Alfred Lim. Recent developments include the 2024 acquisition of CK Health Plus Sdn Bhd for US$15 million in shares, providing exclusive distribution rights for bioenergy cabins and collagen products in Malaysia and enabling direct selling of holistic wellness items; a 2025 strategic partnership between subsidiary CK Health Plus and SafeRock India to expand bioenergy capsule therapies, Helixé supplements, and network marketing into the Indian wellness market; and a letter of intent to acquire GO POSB Organoids Pte Ltd, a Singapore biotech firm specializing in stem cell technology, to bolster biotechnology capabilities.